26th Annual Scientific Assembly

AAEM Young Physician Section (YPS) Poster Competition

This competition is designed to recognize outstanding research achievements by young physicians in emergency medicine. Members of YPS-AAEM and AAEM members who meet the YPS membership criteria are eligible to submit their research for a poster competition.


Competition Schedule

Wednesday, April 22, 2020 | 10:15am-12:05pm | Ahwatukee B




Identification of Arrhythmia Using Outpatient Cardiac Monitoring
Alexander Bracey, MD


Gender Distribution of Editorial Board Members Among Emergency Medicine Journals
Alexandra Mannix, MD


Intensive Cryotherapy In The Emergency Department (ICED): A Randomized Controlled Trial
Eric Leroux, MD MBA


A Randomized Controlled Trial of Adding Corticosteroid to H1-Antihistamine in Acute Urticaria
Pakhawadee Palungwachira, MD


Judges' Deliberation

*This is not an educational track and there will be no CME for these sessions. AAEM membership is a pre-requisite for participation.


Eligibility for Awards

New this year: The top 4 abstracts will be selected for oral presentation at AAEM20. All other abstract submissions are invited to display their research as a poster. The presenter of the oral abstract judged to represent the most outstanding research achievement will receive a $1,000 honorarium, while second and third place will receive $500 and $250 honoraria, respectively.


Abstract Submission Instructions

Please read the abstract submission instructions carefully. The deadline and space requirements are strictly enforced in order to give all authors an equal opportunity to submit their data in the same amount of space and under the same time constraints.

  1. Requirements for Eligibility to Submit
    • YPS-AAEM Member — In order to be eligible for consideration, the first author and principal investigator of each abstract submitted must be a current YPS member. 
      — OR —
    • AAEM Member that is Eligible for the YPS Membership — In order to be eligible for consideration, the first author and principal investigator of each abstract submitted must be an AAEM member within the first five years of professional practice after residency or fellowship training.
  2. Submission Deadline
    • Electronic submissions will be accepted beginning September 9, 2019.
    • Abstract receipt deadline for electronic submission is 11:59pm CST on November 4, 2019.
  3. There is no fee for submitting an abstract. All abstracts must be submitted and presented in English.
  4. You must submit both a blind and formal version of your abstract.
  5. If you have questions regarding the abstract submissions for the 26th Annual Scientific Assembly, please call AAEM at (800) 884-2236 or email Rebecca Sommer at rsommer@aaem.org.


Competitions are now closed.


Abstract Submission Guidelines

Author Information
You will need to submit the author’s name, address, telephone, and fax numbers, as well as an email address. Only the first author and principal investigator listed on the submission form will be notified of abstract acceptance.  The first author and principal investigator must be an YPS-AAEM member or an AAEM member that is eligible for YPS. Only one individual may submit an abstract through the online submission portal. If your submission is accepted for display at Scientific Assembly, you may include the names of co-authors and co-submitters on the display.

Indicate what monies have funded the research, if any.

Disclosure of Relevant Financial Relationships
In accordance with the essentials and standards set forth by the Accreditation Council for Continuing Medical Education, as well as guidelines proposed by the Food and Drug Administration and endorsed by the American Medical Association, an author with a conflict of interest with the content of their abstract must disclose that conflict prior to presentation. A conflict of interest includes, but is not limited to, any relevant financial relationship in a company, product or procedure mentioned in the abstract or in the presentation to be given at the conference. The authors must complete the disclosure form included in the electronic submission. A conflict in and of itself will not eliminate an abstract from consideration.

Previous Presentations of Abstracts
No abstract published as an article on or before October 1, 2018, may be submitted for this competition. Abstracts that have been presented at the national meetings of other organizations should not be submitted for consideration.

Informed Consent
Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966; 14:103) and must meet all the requirements governing informed consent of the country in which the research was performed.

Abstract Publication
Ownership of abstracts not accepted reverts to the authors.

Use of Abstracts for Education
Submitters will be asked for permission for AAEM to use accepted abstracts for online continuing medical education purposes. All authors and contributors will be appropriately credited.

Notification of Abstract Selection
The presenting author of all abstracts submitted by November 4, 2019, will receive notification of acceptance or rejection in February 2020.

Withdrawals and Revisions
Withdrawals and revisions must be received in writing to rsommer@aaem.org by November 11, 2019. No changes can be submitted after that date.

Abstract Formatting

  1. Use 12-point Times New Roman (or similar) type. Limit text to 2,500 characters, including spaces, and single space all text in the body of the abstract. The 2,500 character limit does not include abstract titles and authors.
  2. Do not indent the title. Capitalize only the first letter of each word in the title. List author names using initials only for first and middle names. Underline author names continuously. Include institution, city, and state where research was performed. When submitting the blind copy, omit author names, institution, city, state or any other identifier where research was performed. Omit degrees, titles, institutional appointments, street addresses, and ZIP codes. Single space entire abstract. The left-hand margin of the abstract’s text should be perfectly aligned.
  3. Use of abbreviations — The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word it represents. Numerals rather than words should indicate numbers, except to begin sentences.
  4. Use of drug names — Each time a proprietary drug name is used in the abstract, the first letter is capitalized. Nonproprietary (generic) drug names are preferred and are not capitalized.
  5. Structuring the abstract — Structured abstracts facilitate explicit presentation of critical information and objective assessment of scientific validity. Each abstract should include the following topic headings. It is not necessary to begin a new line or leave extra space between topic headings.

Objectives: A precise statement of the purpose of the study or the pre-study hypothesis. This may be preceded by a brief introduction summarizing past work or relevant controversies that place the study in perspective.

Methods: A brief statement of the methods used, including pertinent information about the study design, setting, participants, subjects, interventions, and observations.

Results: A summary of the results presented in sufficient detail to support the conclusions.

Conclusions: Conclusions should be succinctly stated and firmly supported by the data presented. Note important limitations.


Top Submissions from the 25th Annual Scientific Assembly

1st Place: Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-Analysis - Michael Gottlieb, MD RDMS FAAEM

2nd Place: Is Point-Of-Care Ultrasound a Reliable Predictor of Outcome During Non-Shockable Cardiac Arrest? - Katharine Burns, MD FAAEM

3rd Place: Financial Implications of Inefficient Decision Making - Kraftin E. Schreyer, MD CMQ FAAEM